Global Endocrinology Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 154473
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 131
  • list Pharmaceuticals and Healthcare

Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.

Scope of the Report:

This report focuses on the Endocrinology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

One of the market drivers is increase in prevalence of endocrine hormone-related diseases.

The worldwide market for Endocrinology Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

AbbVie

AstraZeneca

Eli Lilly

Merck

Novo Nordisk

Sanofi

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Diabetes Drugs

Testosterone Replacement Drugs

Human Growth Hormone Drugs

Thyroid Hormone Disorder Drugs

Market Segment by Applications, can be divided into

Hospitals

Commercial Laboratories

Ambulatory Care Centres

Other Setting

There are 15 Chapters to deeply display the global Endocrinology Drugs market.

Chapter 1, to describe Endocrinology Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Endocrinology Drugs, with sales, revenue, and price of Endocrinology Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Endocrinology Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Endocrinology Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Endocrinology Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Endocrinology Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Diabetes Drugs

1.2.2 Testosterone Replacement Drugs

1.2.3 Human Growth Hormone Drugs

1.2.4 Thyroid Hormone Disorder Drugs

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Commercial Laboratories

1.3.3 Ambulatory Care Centres

1.3.4 Other Setting

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AbbVie

2.1.1 Business Overview

2.1.2 Endocrinology Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Endocrinology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca

2.2.1 Business Overview

2.2.2 Endocrinology Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca Endocrinology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Endocrinology Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Endocrinology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 Endocrinology Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck Endocrinology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novo Nordisk

2.5.1 Business Overview

2.5.2 Endocrinology Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novo Nordisk Endocrinology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sanofi

2.6.1 Business Overview

2.6.2 Endocrinology Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sanofi Endocrinology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Endocrinology Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Endocrinology Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Endocrinology Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Endocrinology Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Endocrinology Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Endocrinology Drugs Market Analysis by Regions

4.1 Global Endocrinology Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Endocrinology Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Endocrinology Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Endocrinology Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Endocrinology Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Endocrinology Drugs Sales and Growth Rate (2013-2018)

4.5 South America Endocrinology Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Endocrinology Drugs Sales and Growth Rate (2013-2018)

5 North America Endocrinology Drugs by Countries

5.1 North America Endocrinology Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Endocrinology Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Endocrinology Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Endocrinology Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Endocrinology Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Endocrinology Drugs Sales and Growth Rate (2013-2018)

6 Europe Endocrinology Drugs by Countries

6.1 Europe Endocrinology Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Endocrinology Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Endocrinology Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Endocrinology Drugs Sales and Growth Rate (2013-2018)

6.3 UK Endocrinology Drugs Sales and Growth Rate (2013-2018)

6.4 France Endocrinology Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Endocrinology Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Endocrinology Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Endocrinology Drugs by Countries

7.1 Asia-Pacific Endocrinology Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Endocrinology Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Endocrinology Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Endocrinology Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Endocrinology Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Endocrinology Drugs Sales and Growth Rate (2013-2018)

7.5 India Endocrinology Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Endocrinology Drugs Sales and Growth Rate (2013-2018)

8 South America Endocrinology Drugs by Countries

8.1 South America Endocrinology Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Endocrinology Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Endocrinology Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Endocrinology Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Endocrinology Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Endocrinology Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Endocrinology Drugs by Countries

9.1 Middle East and Africa Endocrinology Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Endocrinology Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Endocrinology Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Endocrinology Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Endocrinology Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Endocrinology Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Endocrinology Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Endocrinology Drugs Sales and Growth Rate (2013-2018)

10 Global Endocrinology Drugs Market Segment by Type

10.1 Global Endocrinology Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Endocrinology Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Endocrinology Drugs Revenue and Market Share by Type (2013-2018)

10.2 Diabetes Drugs Sales Growth and Price

10.2.1 Global Diabetes Drugs Sales Growth (2013-2018)

10.2.2 Global Diabetes Drugs Price (2013-2018)

10.3 Testosterone Replacement Drugs Sales Growth and Price

10.3.1 Global Testosterone Replacement Drugs Sales Growth (2013-2018)

10.3.2 Global Testosterone Replacement Drugs Price (2013-2018)

10.4 Human Growth Hormone Drugs Sales Growth and Price

10.4.1 Global Human Growth Hormone Drugs Sales Growth (2013-2018)

10.4.2 Global Human Growth Hormone Drugs Price (2013-2018)

10.5 Thyroid Hormone Disorder Drugs Sales Growth and Price

10.5.1 Global Thyroid Hormone Disorder Drugs Sales Growth (2013-2018)

10.5.2 Global Thyroid Hormone Disorder Drugs Price (2013-2018)

11 Global Endocrinology Drugs Market Segment by Application

11.1 Global Endocrinology Drugs Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Commercial Laboratories Sales Growth (2013-2018)

11.4 Ambulatory Care Centres Sales Growth (2013-2018)

11.5 Other Setting Sales Growth (2013-2018)

12 Endocrinology Drugs Market Forecast (2018-2023)

12.1 Global Endocrinology Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Endocrinology Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Endocrinology Drugs Market Forecast (2018-2023)

12.2.2 Europe Endocrinology Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Endocrinology Drugs Market Forecast (2018-2023)

12.2.4 South America Endocrinology Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Endocrinology Drugs Market Forecast (2018-2023)

12.3 Endocrinology Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Endocrinology Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Endocrinology Drugs Market Share Forecast by Type (2018-2023)

12.4 Endocrinology Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Endocrinology Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Endocrinology Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Endocrinology Drugs Picture

Table Product Specifications of Endocrinology Drugs

Figure Global Sales Market Share of Endocrinology Drugs by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery